Patient Demographic / Label. Infection Control Care Plan for a patient with MRSA

Similar documents
Infection Control Care Plan for a patient with Group A Streptococcus

Infection Control Care Plan for a patient with confirmed/ suspected Active Pulmonary Tuberculosis. Patient Demographic / Label

Infection Control Care Plan. Patient Demographic / label. Hospital: Ward:

Policy Objective To provide Health Care Workers (HCWs) with details of the precautions necessary to minimise the risk of MRSA cross-infection.

Infection Prevention Control Team

MRSA. Information for patients Infection Prevention and Control. Large Print

MRSA. Information for patients Infection Prevention and Control

STANDARD OPERATING PROCEDURE (SOP) TERMINAL CLEAN OF ISOLATION ROOMS

Isolation Care of Patients in Isolation due to Infection or Disease

Policy for the control and management of patients colonised or infected with Meticillin Resistant Staphylococcus aureus (MRSA)

The Clatterbridge Cancer Centre. NHS Foundation Trust MRSA. Infection Control. A guide for patients and visitors

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015

NHS GREATER GLASGOW & CLYDE CONTROL OF INFECTION COMMITTEE STANDARD OPERATING PROCEDURE (SOP) GROUP A STREPTOCOCCUS (Streptococcus pyogenes)

Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE)

STANDARD OPERATING PROCEDURE (SOP) SCABIES POLICY TRANSMISSION BASED PRECAUTIONS.

MRSA. Information for patients and carers. Delivering the best in care. UHB is a no smoking Trust

MRSA: Help us to help to help you

infection control MRSA Information for patients (Methicillin Resistant Staphylococcus aureus)

Health Professionals (NMAHPs) Lanarkshire Infection Control Committee (LICC) Emer Shepherd, Head of Infection Prevention and Control

Disclosure Status (B) B Can be disclosed to patients and the public

Methicillin Resistant Staphylococcus aureus (MRSA) screening and decolonisation

MRSA Management of patients with meticillin-resistant staphylococcus aureus. Ref IPC v3. Status: Approved Document type: Procedure

Skin and Nasal Decolonization for Adult

Infection Prevention and Control (IPC) Standard Operating Procedure for LICE (PEDICULOSIS AND PHTHIRIASIS) in a healthcare setting

Methicillin Resistant Staphylococcus aureus (MRSA) Procedure

Patient Information Service. Infection prevention and control department MRSA

Policy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection.

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas

Everyone Involved in providing healthcare should adhere to the principals of infection control.

Standard Precautions must always be used in addition to Transmission Based Precautions.

Clostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions

Hereford Hospitals NHS Trust

Preventing Infection Workbook

Policy Number F9 Effective Date: 17/07/2018 Version: 3 Review Date: 17/07/2019

Outbreak Management 2015

Chapter 10. medical and Surgical Asepsis. safe, effective Care environment. Practices that Promote Medical Asepsis

Policy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection.

The most up to date version of this policy can be viewed at the following website:

Children s needs: Protection from infection, clean hygienic environment, instruction about personal hygiene

Checklists for Preventing and Controlling

INCREASED INCIDENT /OUTBREAK OF DIARRHOEA AND/OR VOMITING

Methicillin-Resistant Staphylococcus aureus Health and Social Care Act 2010 Contributes to CQC Core Standard Outcome 8

ISOLATION TABLE OF CONTENTS STANDARD PRECAUTIONS... 2 CONTACT PRECAUTIONS... 4 DROPLET PRECAUTIONS... 6 ISOLATION PROCEDURES... 7

Vancomycin-Resistant Enterococcus (VRE)

Clostridium difficile Infection (CDI) Trigger Tool

SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE)

METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): CONTROL AND PREVENTION

Infection Prevention Control Team

Infection Prevention, Control & Immunizations

Patient Information Service. Infection prevention and control department MRSA

Trust Policy METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS

The Management of Patients with Meticillin Resistant Staphylococcus Aureus Policy (MRSA)

What you can do to help stop the spread of MRSA and other infections

CLEANING OF NEAR PATIENT HEALTHCARE EQUIPMENT

Developed in response to: Best Practice Infection Prevention and Control

Clostridium difficile Infection (CDI) Trigger Tool

Guidance for the Selection and Use of Personal Protective Equipment (PPE) in Healthcare Settings

Infection Control Policy and Procedure Manual. Post-Anesthesia Care Unit (Recovery Room) Page 1 of 6

MRSA Policy Best Practice Guidelines. Printed copies must not be considered the definitive version. August 2017 Scope. Infection Control Team

Community Infection Prevention and Control Guidance for Health and Social Care

Standard Operating Procedure (SOP)

Meticillin Resistant Staphylococcus Aureus (MSRA) for Community Settings Policy

METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change

Infection Control and Prevention On-site Review Tool Hospitals

Standard Precautions

MRSA INFORMATION LEAFLET for patients and relatives. both in hospital and the community. MRSA is a type of

Infection Control Policy EDITION 5

Infection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases

STANDARD PRECAUTIONS POLICY Page 1 of 8 Reviewed: May 2017

Healthcare Associated Infection (HAI) inspection tool

Infection Prevention and Control Guidelines: Spillage Management

Infection Prevention and Control

Guideline for the Management of Patients with Known or Suspected Diarrhoea / Viral Gastroenteritis

HYGIENE POLICY PURPOSE POLICY STATEMENT 1. VALUES 2. SCOPE 3. BACKGROUND AND LEGISLATION

Oregon Health & Science University Department of Surgery Standard Precautions Policy

MRSA in Holland What is Behind the Success Gertie van Knippenberg-Gordebeke

Infection Prevention and Control and Isolation Authored by: Infection Prevention and Control Department

Learning Resource Pack: Source Isolation Version 2 (Aug 2005)

Community Infection Prevention and Control Guidance for Health and Social Care

Developed in response to: Health and Social Care Act 2008 Contributes CQC Core Standard Outcome 8

Hygiene Policy. Arrangements for Review:

Guidance for Care Homes SAMPLE. Preventing Infection Workbook. Guidance for Care Homes. 10th Edition. Name. Job Title 1

Ebola guidance package

: Hand. Hygiene Policy NAME. Author: Policy and procedure. Version: V 1.0. Date created: 11/15. Date for revision: 11/18

03/09/2014. Infection Prevention and Control A Foundation Course. Linen management

Preventing Infection in Care

Infection Control Manual - Section 7 Cleaning & Disinfection. Infection Control Committee. Infection Prevention Control Team

Clostridium difficile GDH positive (Glutamate Dehydrogenase) toxin negative

Infection Control Safety Guidance Document

Trust Policy, Infection Control

Approval Signature: Date of Approval: December 6, 2007 Review Date:

BLOOD AND BODILY FLUID GUIDELINES

Clinical Director for Women s and Children s Division

A guide for patients and visitors MRSA. A guide for patients and visitors

Hand washing and Hygiene and Infection Control Policy

Infection Prevention and Control. Carbapenemase Producing Enterobacteriaceae (CPE)

METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): CONTROL AND PREVENTION

Guidelines on Infection Prevention and Control for Cork Kerry Community Healthcare 06: Transmission Based Precautions

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust

The Ebola Virus: Infection Control Precautions

Transcription:

Patient Demographic / Label Infection Control Care Plan for a patient with MRSA Statement: This Care Plan should be used with patients who are suspected of or are known to have MRSA. This Care Plan should be followed to reduce the risk of transmitting MRSA to other patients, staff, carers and visitors. If it is not possible to follow this Care Plan, please notify a member of the Infection Control Team who will carry out a risk assessment on how best to care for this patient. Date No Issue / Problem Action to be taken Ongoing Assessment 1 Accommodation Isolate the patient in a single room with en suite facilities. If en suite is not available ensure access to own commode. A risk assessment should be carried out by the clinical team to determine the suitability of the patient for isolation. If not suitable a daily review should be carried out and documented in case notes. Place an isolation sign on the outside of the door. Door must be kept closed. If this is not possible document the reason in the case notes daily. Patients can be removed from isolation when 2 full consecutive negative screens have been obtained at intervals of no less than 72 hours, beginning at least 48 hours after decolonisation therapy has been completed. 2 Hand Hygiene Hand hygiene must be performed with liquid soap and water or alcohol hand gel after contact with the patient, their environment or equipment and on leaving isolation Use gloves to prevent hand contamination. Decontaminate hands after removal of gloves with liquid soap and water or alcohol hand gel. Ensure hand washing facilities are offered to patient especially after using toilet and prior to eating. 3 Personal Protective Equipment (PPE) Disposable yellow aprons and gloves must be worn for all direct contact with the patient or patient s environment/ equipment. Gloves and yellow aprons are single use and must be disposed of into the clinical waste stream after use and then hands must be decontaminated with liquid soap and water. Where possible, equipment such as chairs, hoist sling etc should be used by that patient only and kept in the 4 Decontamination of Patient Equipment Page 1 of 5

If equipment is taken out of the room it must be cleaned with 1000ppm chlorine based detergent (10,000ppm if contaminated with body fluids/ blood). Keep items and equipment to a minimum in Date No Issue / problem Action to be taken Ongoing Assessment 5 Specimens/Treatment IPCN will advise, National Screening to be followed.. Specimens required : Anterior nares Perineum * Skin lesions/ wounds. Catheter sites, e.g. Central Venous Catheters, Hickman Lines, Catheter urine Sputum from patients with a productive cough. Umbilicus (neonates only) If patient refuses perineal screening they should be offered throat screening. Any modification to the standard screening should be recorded in the notes Treatment: Declonisation therapy should be considered for patients who are MRSA positive. Treatment of Mupirocin resistant strains of MRSA will be advised by the ICT Colonised patients should receive 2 attempts at Decolonisation therapy. If unsuccessful, continued therapy should be discussed with Medical staff. Decolonisation therapy should be carried out for 5 days then stopped. Patient should be re-screened 48 hours after all treatment for decolonisation has stopped. See treatment and screen sheet for further advice. See page 4. 6 Linen Place used linen in water soluble bag, then clear polythene bag, then into laundry bag. Do not store clean linen in Bed linen should be changed daily Page 2 of 5

7 Waste Dispose of all waste into a clinical healthcare waste bag inside A foot operated bin should be used. When the waste bag is ¾ full (and daily), fasten securely and label with ward identification number. 8 Environmental cleaning 9 Information to Patient and Carers To maintain confidentiality advise domestic staff that the patient is being isolated. Floor, surfaces, sink, toilet etc. must be cleaned twice daily by domestic staff using chlorine based detergent, Refer to SOP Twice Daily Clean of Isolation Rooms. www.nhsggc.org.uk/infectioncontrol Nursing staff are responsible for the cleaning of patient related equipment twice daily using chlorine based detergent. When room vacated nursing staff should clean patient related equipment with chlorine based detergent, and remove it from the Domestic staff should then carry out a thorough terminal clean of the When dry the room can be used. Refer to SOP Terminal Clean of Isolation Room. www.nhsggc.org.uk/infectioncontrol Ensure patient / relative is given information on MRSA and an opportunity to discuss this. Document this in clinical notes. Ensure that all persons visiting the patient are aware that patient is in isolation, 10 Visitor restrictions Visitors must be instructed to report to nurse in charge before entering room Vulnerable people such as young children should be discouraged from visiting. Aprons and Gloves are NOT required to be worn by visitors, unless they are involved in clinical care but they should be instructed to wash their hands using soap and water or alcohol hand gel on leaving the Page 3 of 5

Date No Issue / problem Action to be taken Ongoing Assessment 11 Personal clothing There are no special washing instructions. Relatives should wash their hands after handling used linen. Personal laundry contaminated with blood or body fluids should be placed in a patient clothing alginate bag before being given to the carer or relative for home laundering. Provide a Home Laundry leaflet. 12 Transfer to another Department or Hospital 13 Psychological impact of being isolated Prior to transfer the receiving area/ department, e.g. radiology must be informed of the patient s MRSA status. Patients in isolation may be prone to feelings of loneliness and depression as well as feeling stigmatised. These feelings can be lessened by: Ensuring patient understands need for isolation and encouraged to express concerns. Provide verbal and/ or written information about the reason, including leaflet if available. Ensure patient has items to relieve boredom and provide distraction, e.g. TV, newspapers. Page 4 of 5

Date: Nose Perineum Screening Results ERADICATION REGIMEN FOR MRSA This regimen should be commenced on the advice of the Infection Control Nurse/ Doctor. Use this regimen for 5 days then stop. Chlorhexidine Gluconate 4% (Hydrex) Whole Body Wash Use for 5 days 1. Apply neat to the skin. 2. Pay particular attention to the following areas: hairline, around nostrils, under the arms, perineum/ groin, feet. 3. Wash body with disposable cloth or wipes then rinse skin thoroughly. 4. After washing provide the patient with a change of clothing/ pyjamas and bed linen. 5. NOTE: If Chlorhexidine Gluconate 4% (Hydrex) causes irritation of the skin discontinue use and contact Infection Control Nurse. Mupirocin (Bactroban) Nasal: Use 3 times a day for 5 days Apply to anterior nares 3 times a day as follows: 1. Unscrew the cap and squeeze a small amount (about the size of a matchhead) onto the little finger or a cotton bud. 2. Apply to inside of both nostrils. 3. Close the nostril by momentarily pinching the nose together and massaging to spread the ointment. Mupirocin should only be used for 2 five-day courses and should never be used for prolonged courses or used repeatedly. Mupirocin Resistant MRSA Nasal Naseptin applied to the inner surface of each nostril four times daily for five days should replace Mupirocin. Naseptin should be avoided in patients with peanut allergy. Please discuss an alternative with a microbiologist. Patients should not be removed from isolation/ cohort until at least 2 full consecutive negative screens have been obtained at intervals of no less than 72 hours, beginning at least 48 hours after antibiotic/ decolonisation therapy has been completed. Patients should only be removed from side room after consulting the ICT. 4% Chlorhexidine (Hydrex) Whole Body NASAL BACTROBAN Wash Date Commenced Date completed Date Commenced Date completed Re-Screen date Documentation Control * ICT Only Date of issue May 2015 (updated) Date of review May 2017 Page 5 of 5